Compumedics Limited (ASX:CMP)

Compumedics Statistics

Total Valuation

Compumedics has a market cap or net worth of AUD 54.73 million. The enterprise value is 65.92 million.

Market Cap	54.73M
Enterprise Value	65.92M

Important Dates

The last earnings date was Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Compumedics has 192.04 million shares outstanding. The number of shares has increased by 2.57% in one year.

Current Share Class	192.04M
Shares Outstanding	192.04M
Shares Change (YoY)	+2.57%
Shares Change (QoQ)	-4.26%
Owned by Insiders (%)	56.26%
Owned by Institutions (%)	3.07%
Float	61.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	19.00
PS Ratio	1.07
PB Ratio	2.51
P/TBV Ratio	2.51
P/FCF Ratio	117.20
P/OCF Ratio	80.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.26, with an EV/FCF ratio of 141.16.

EV / Earnings	-51.82
EV / Sales	1.29
EV / EBITDA	22.26
EV / EBIT	92.33
EV / FCF	141.16

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.64.

Current Ratio	1.10
Quick Ratio	0.55
Debt / Equity	0.64
Debt / EBITDA	4.69
Debt / FCF	29.72
Interest Coverage	0.56

Financial Efficiency

Return on equity (ROE) is -6.35% and return on invested capital (ROIC) is 1.43%.

Return on Equity (ROE)	-6.35%
Return on Assets (ROA)	0.94%
Return on Invested Capital (ROIC)	1.43%
Return on Capital Employed (ROCE)	3.21%
Revenue Per Employee	329,290
Profits Per Employee	-8,206
Employee Count	155
Asset Turnover	1.08
Inventory Turnover	1.44

Taxes

In the past 12 months, Compumedics has paid 679,000 in taxes.

Income Tax	679,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.56% in the last 52 weeks. The beta is 0.46, so Compumedics's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-6.56%
50-Day Moving Average	0.30
200-Day Moving Average	0.29
Relative Strength Index (RSI)	48.15
Average Volume (20 Days)	116,443

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Compumedics had revenue of AUD 51.04 million and -1.27 million in losses. Loss per share was -0.01.

Revenue	51.04M
Gross Profit	30.99M
Operating Income	714,000
Pretax Income	-593,000
Net Income	-1.27M
EBITDA	1.94M
EBIT	714,000
Loss Per Share	-0.01

Balance Sheet

The company has 2.69 million in cash and 13.88 million in debt, giving a net cash position of -11.19 million or -0.06 per share.

Cash & Cash Equivalents	2.69M
Total Debt	13.88M
Net Cash	-11.19M
Net Cash Per Share	-0.06
Equity (Book Value)	21.82M
Book Value Per Share	0.12
Working Capital	3.10M

Cash Flow

In the last 12 months, operating cash flow was 681,000 and capital expenditures -214,000, giving a free cash flow of 467,000.

Operating Cash Flow	681,000
Capital Expenditures	-214,000
Free Cash Flow	467,000
FCF Per Share	0.00

Margins

Gross margin is 60.71%, with operating and profit margins of 1.40% and -2.49%.

Gross Margin	60.71%
Operating Margin	1.40%
Pretax Margin	-1.16%
Profit Margin	-2.49%
EBITDA Margin	3.80%
EBIT Margin	1.40%
FCF Margin	0.91%

Dividends & Yields

Compumedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.57%
Shareholder Yield	n/a
Earnings Yield	-2.32%
FCF Yield	0.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Compumedics has an Altman Z-Score of 1.58 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.58
Piotroski F-Score	4